XML 49 R34.htm IDEA: XBRL DOCUMENT v3.24.3
Segment information (Tables)
 9 Months Ended
Nov. 02, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, By Segment
13 weeks ended39 weeks ended
(in millions)November 2, 2024October 28, 2023November 2, 2024October 28, 2023
Sales:
North America segment
$1,262.0 $1,291.1 $4,079.6 $4,353.4 
International segment
83.3 94.0 247.0 289.0 
Other segment
4.1 6.8 24.6 31.1 
Total sales
$1,349.4 $1,391.9 $4,351.2 $4,673.5 
Operating income (loss):
North America segment (1)
$24.1 $39.2 $30.1 $281.0 
International segment (2)
(3.7)(9.0)(20.9)(22.9)
Other segment
(1.6)(3.1)(7.3)(4.8)
Corporate and unallocated expenses (3)
(9.6)(13.8)(43.8)(48.1)
Total operating income (loss)
9.2 13.3 (41.9)205.2 
Interest (expense) income, net(1.0)2.6 10.0 10.0 
Other non-operating income (expense), net0.2 (2.3)2.0 (2.4)
Income (loss) before income taxes$8.4 $13.6 $(29.9)$212.8 
(1)    Operating income during the 13 and 39 weeks ended November 2, 2024 includes $0.8 million and $169.0 million, respectively, of asset impairment charges primarily related to goodwill and indefinite-lived intangible assets recognized in the second quarter; and $5.4 million and $6.2 million, respectively, of restructuring and related charges. Operating income during the 39 weeks ended November 2, 2024 includes $1.1 million of integration-related expenses, primarily severance and retention, incurred for the integration of Blue Nile.
Operating income during the 13 and 39 weeks ended October 28, 2023 includes $7.5 million and $20.1 million, respectively, of integration-related expenses, primarily severance and retention, and exit and disposal costs, and system decommissioning costs incurred for the integration of Blue Nile; and $0.2 million and $4.4 million, respectively, of restructuring charges. Operating income during the 39 weeks ended October 28, 2023 includes a $3.0 million credit to income related to the adjustment of a prior litigation accrual and $5.6 million of net asset impairment charges primarily related to restructuring and integration.
See Note 12, Note 18 and Note 20 for additional information.
(2)    Operating loss during the 13 and 39 weeks ended November 2, 2024 includes $0.4 million and $5.4 million, respectively, of restructuring charges. Operating loss during the 39 weeks ended November 2, 2024 includes $2.5 million of net losses from the previously announced divestiture of the UK prestige watch business and $0.3 million of net asset impairment charges primarily related to planned store closures.
Operating loss during the 13 and 39 weeks ended October 28, 2023 includes restructuring charges of $1.4 million and costs related to the divestiture of the UK prestige watch business of $1.3 million.
    See Note 1 and Note 18 for additional information.
(3)    Operating loss during the 13 and 39 weeks ended November 2, 2024 includes $0.8 million of Chief Executive Officer (“CEO”) transition costs, primarily related to professional fees incurred for the search for the Company’s recently appointed CEO.